Table 1 Clinical parameters before and after administration of dapagliflozin or sitagliptin

78.4 ± 14.3

76.2 ± 1.8

−2.8

<0.001*

77.6 ± 11.6

77.7 ± 11.6

0.1

0.089

0.042*

130.7 ± 15.8

126.5 ± 12.7

−3.2

0.022*

133.2 ± 17.8

131.0 ± 13.3

−1.7

0.611

0.031*

86.9 ± 10.7

82.3 ± 16.0

−5.3

0.188

88.1 ± 9.5

84.4 ± 11.0

−4.2

0.024*

0.242

82.5 ± 10.4

81.6 ± 13.9

−1.1

0.300

81.5 ± 10.3

77.1 ± 10.8

−5.4

0.056

0.344

14.4 ± 1.2

15.1 ± 1.4

4.9

<0.001*

14.2. ± 1.4

14.5 ± 1.5

2.1

0.088

<0.001*

41.9 ± 3.5

44.5 ± 4.0

6.2

<0.001*

41.4 ± 4.3

41.9 ± 4.2

1.2

0.297

<0.001*

34.5 ± 19.4

26.8 ± 12.8

−22.3

<0.001*

33.2 ± 9.8

35.4 ± 14.9

6.6

0.089

<0.001*

46.6 ± 37.0

33.5 ± 24.9

−28.1

<0.001*

42.8 ± 15.0

44.9 ± 18.4

4.9

0.202

<0.001*

53.2 ± 43.0

42.3 ± 47.2

−20.5

0.109

50.9 ± 18.1

52.2 ± 22.0

2.6

0.729

0.107

14.6 ± 4.3

16.8 ± 5.0

15.1

<0.001*

13.5 ± 4.5

15.3 ± 4.6

13.3

0.115

0.367

0.72 ± 0.17

0.74 ± 0.23

2.8

0.173

0.77 ± 0.17

0.81 ± 0.18

5.2

0.110

0.757

86.2 ± 18.4

83.6 ± 23.2

−3.0

0.230

83.5 ± 22.7

79.2 ± 21.4

−5.1

0.003*

0.545

145.8 ± 47.8

122.3 ± 24.9

−16.1

0.002*

144.9 ± 57.9

126.2 ± 43.9

−12.9

0.043*

0.673

7.61 ± 1.15

6.86 ± 0.81

−9.9

<0.001*

7.55 ± 1.64

6.92 ± 1.20

−8.3

0.006*

0.378

2.79 ± 1.39

2.40 ± 1.56

−14.0

0.018*

2.70 ± 1.25

2.78 ± 1.48

3.0

0.633

0.190

6.0 ± 3.4

7.6 ± 4.2

26.7

<0.001*

6.2 ± 5.3

6.2 ± 3.8

0

0.899

0.002*